Skip to main content
. 2014 Nov 17;7:2111–2120. doi: 10.2147/OTT.S71646

Figure 7.

Figure 7

Disease-free survival estimates for patients with concurrent TOP2A-positive and TLE3-negative tumors, in comparison with all other patients.

Abbreviations: TLE3, transducin-like enhancer of split 3; TOP2A, topoisomerase II alpha.